Interactions of Leptin and the Melanocortin System
瘦素和黑皮质素系统的相互作用
基本信息
- 批准号:9768441
- 负责人:
- 金额:$ 41.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:ADRA2A geneAcuteAdipocytesAdipose tissueAdrenergic ReceptorAdultAutomobile DrivingBehavioralBloodBody WeightBody fatBrainComplexCuesDataDevelopmentDiabetes MellitusDiseaseEatingEndocrineEnergy MetabolismExposure toFastingFatty acid glycerol estersFood EnergyFunctional disorderGenetically Engineered MouseGlucoseHandHepaticHomeostasisHypothalamic structureImpairmentIncidenceInsulinInsulin ResistanceLeptinLipidsLiverMediatingMetabolicMetabolismModelingMolecularMusNervous system structureNeuraxisNeuronsNeurosecretory SystemsNutritional statusObesityPathway interactionsPlayPro-OpiomelanocortinProcessProductionRegulationRoleSignal TransductionSurfaceSympathetic Nervous SystemSystemTestingTissuesVisceralbaseblood glucose regulationdesigner receptors exclusively activated by designer drugsdiabetes mellitus therapyenergy balancefallsfatty acid oxidationfeedinggenetic manipulationglucose metabolismglucose productioninsulin sensitivityleptin receptorlipid biosynthesisliver developmentliver functionmouse modelprenatalreceptortargeted treatment
项目摘要
Abstract
The increasing rates of obesity and diabetes highlight the need to understand the brain circuits and cellular
mechanisms regulating energy balance and glucose homeostasis. Prominent among these is the central leptin-
melanocortin system, which includes the pro-opiomelanocortin (POMC) neurons, subsets of which express
leptin receptors (LEPRs). Understanding how leptin differentially regulates energy balance versus glucose
homeostasis is key for the development of anti-obesity and anti-diabetes therapies. Early observations based
on prenatal genetic manipulations led to the widely-held model that LEPR-expressing POMC neurons
mediated the metabolic actions of leptin, however, evidence now suggests that these pathways are more
complex than originally anticipated. The current application extends our early developmental models by directly
testing the role of leptin action in adult melanocortin neurons in regulating glucose metabolism and responding
to dynamic challenges, including fasting and cold exposure. We also have in hand a model in which liver
insulin resistance can be induced in a temporal manner, allowing us to investigate the role of the leptin-
melanocortin pathway in its development. These studies will broaden our understanding of the functional
mechanism by which the leptin-melanocortin system regulates endocrine, autonomic, and behavioral functions,
particularly at the level of adipose tissues and liver.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOEL K. ELMQUIST其他文献
JOEL K. ELMQUIST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOEL K. ELMQUIST', 18)}}的其他基金
Leptin Reduction as a Potent Mitigative Strategy for the Treatment of PASC
瘦素减少是治疗 PASC 的有效缓解策略
- 批准号:
10554019 - 财政年份:2021
- 资助金额:
$ 41.81万 - 项目类别:
Ventromedial Hypothalamic Regulation of Metabolic Changes Induced by Exercise
运动引起的代谢变化的下丘脑腹内侧调节
- 批准号:
10018902 - 财政年份:2019
- 资助金额:
$ 41.81万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Standard Grant